Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide, a Rising Star in Type 2 Diabetes

Overview of attention for article published in Journal of Diabetes Research, April 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 58,050 followers.

RT @ValleAlfonso: 📖Research Progress on the GIP/GLP-1 Receptor Coagonist #Tirzepatide, a Rising ⭐️ in Type 2 Diabetes 👉 hypoglycaemic and…

RT @ValleAlfonso: 📖Research Progress on the GIP/GLP-1 Receptor Coagonist #Tirzepatide, a Rising ⭐️ in Type 2 Diabetes 👉 hypoglycaemic and…

RT @ValleAlfonso: 📖Research Progress on the GIP/GLP-1 Receptor Coagonist #Tirzepatide, a Rising ⭐️ in Type 2 Diabetes 👉 hypoglycaemic and…

RT @ValleAlfonso: 📖Research Progress on the GIP/GLP-1 Receptor Coagonist #Tirzepatide, a Rising ⭐️ in Type 2 Diabetes 👉 hypoglycaemic and…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.